Profile for Kiniksa Pharmaceuticals Ltd. (KNSA)

$ 22.85   -0.20 (-0.87%) Volume: 171.17k 4:00 PM EDT Jul 7, 2020
After Hours:  $ 22.01   -0.84 (-3.68%) Volume: 359 5:03 PM EDT Jul 7, 2020
Business Description:
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
Address: 2 Church Street, Clarendon House, Hamilton, BMU, HM11
Telephone: +44 8081896257 Website: http://www.kiniksa.com
Facsimile: N/A Email: [email protected]
Details
CEO: Sanj K. Patel
Employees: 137 Market Cap: 1.34b
Issue Type: CS
Auditor: PricewaterhouseCoopers LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1730430
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: